Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,489 | -39,961 | -27,099 | -11,949 | -37,966 |
| Depreciation Amortization | 550 | 1,216 | 799 | 380 | 512 |
| Accounts receivable | 1,882 | 2,058 | 2,058 | 1,891 | 49,032 |
| Accounts payable and accrued liabilities | 188 | -29 | 8 | 327 | -434 |
| Other Working Capital | -26,415 | -18,293 | -11,400 | -8,983 | 44,128 |
| Other Operating Activity | 9,161 | 5,116 | 2,473 | 48 | -38,836 |
| Operating Cash Flow | $-70,123 | $-49,893 | $-33,161 | $-18,286 | $16,436 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -790 | -465 | -236 | -46 | -838 |
| Purchase Of Investment | -211,973 | -189,404 | -154,889 | -75,235 | -192,480 |
| Sale Of Investment | 200,237 | 170,737 | 121,237 | 70,137 | 140,250 |
| Investing Cash Flow | $-12,526 | $-19,132 | $-33,888 | $-5,144 | $-53,068 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 14,911 |
| Common Stock Issued | 96,133 | 79,113 | 78,880 | 75,849 | 10,467 |
| Other Financing Activity | -1,313 | -1,174 | -1,174 | -1,174 | -678 |
| Financing Cash Flow | $94,820 | $77,939 | $77,706 | $74,675 | $24,700 |
| Beginning Cash Position | 28,088 | 28,088 | 28,088 | 28,088 | 40,020 |
| End Cash Position | 40,259 | 37,002 | 38,745 | 79,333 | 28,088 |
| Net Cash Flow | $12,171 | $8,914 | $10,657 | $51,245 | $-11,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,123 | -49,893 | -33,161 | -18,286 | 16,436 |
| Capital Expenditure | -790 | -465 | -236 | -46 | -838 |
| Free Cash Flow | -70,913 | -50,358 | -33,397 | -18,332 | 15,598 |